Abstract
Purpose
To explore the underlying risk factors and to prevent misdiagnosis of cervical intraepithelial neoplasia (CIN) coexisted with vaginal intraepithelial neoplasia (VaIN).
Methods
Clinical data of patients pathologically diagnosed with CIN were collected from January 2017 to December 2018. A total of 446 cases were analyzed, including 406 cases of single lesions (‘CIN single’ group) and 40 cases complicated with VAIN (‘VAIN concurrent’ group).
Results
The median age of the VAIN concurrent group was 53 years (46.25–59 years), and the median age of the CIN single group was 44 years (36–50 years). Regarding menopausal status, there were 28 cases (70.0%) in the VAIN concurrent group and 89 cases (21.9%) in the CIN single group (P < 0.005). The median load of high-risk human papillomavirus (Hr-HPV) in the VAIN concurrent and CIN single group was 923.4 relative light units/cutoff (RLU/CO) (145–2172.2 RLU/CO) and 229.155 RLU/CO (18.615–638.1275 RLU/CO), respectively (P = 0.037). The results revealed that the menopausal status was an independent risk factor for VAIN occurrence in CIN patients. The risk of VAIN in menopausal patients was higher than that in non-menopausal CIN patients (OR = 8.311, 95% CI 4.062–17.005). Age and HPV load were also related to the concurrence of VAIN and CIN.
Conclusion
Examinations regarding vaginal screening are of great importance in the diagnosis of perimenopausal and postmenopausal CIN patients, especially patients with Hr-HPV load. Colposcopy and tissue biopsy should also be performed, when necessary, to avoid misdiagnosis and the appearance of vaginal lesions.
Similar content being viewed by others
References
Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013;17:S1–27.
Siegler E, Segev Y, Mackuli L, Auslender R, Shiner M, Lavie O. Vulvar and vaginal cancer, vulvar intraepithelial neoplasia 3 and vaginal intraepithelial neoplasia 3: experience of a referral institute. Isr Med Assoc J. 2016;18:286–9.
Murta EF, Neves Junior MA, Sempionato LR, Costa MC, Maluf PJ. Vaginal intraepithelial neoplasia: clinical-therapeutic analysis of 33 cases. Arch Gynecol Obstet. 2005;272:261–4.
Gunderson CC, Nugent EK, Elfrink SH, Gold MA, Moore KN. A contemporary analysis of epidemiology and management of vaginal intraepithelial neoplasia. Am J Obstet Gynecol. 2013;208:410.e1-410.e6.
Wee WW, Chia YN, Yam PKL. Diagnosis and treatment of vaginal intraepithelial neoplasia. BJOG. 2012;117:15–7.
Bo C, Lan Z. Clinical analysis of 28 cases of vaginal intraepithelial neoplasia. Chin J Pract Gynecol Obstet 2012;918–20.
Zhao HP, Xue QS, Yu BW, et al. Clinical analysis of 56 cases with vaginal intraepithelial neoplasia after hysterectomy. J Shanghai Jiaotong Univ (Medical Science). 2017;37:661–5.
He Y, Zhao Q, Geng YN, Yang SL, Yin CH, Wu YM. Clinical analysis of cervical intraepithelial neoplasia with vaginal intraepithelial neoplasia. Medicine. 2017;96: e6700.
Frega A, Sopracordevole F, Assorgi C, Lombardi D, Sanctis DEV, Catalano A, et al. Vaginal intraepithelial neoplasia: a therapeutical dilemma. Anticancer Res. 2013;33:29–38.
Song JH, Lee JH, Lee JH, Park JS, Hong SH, Jang HS, et al. High-dose-rate brachytherapy for the treatment of vaginal intraepithelial neoplasia. Cancer Res Treat. 2014;46:74–80.
Kurman RJ, Carcangiu ML, Herrington CS, et al. WHO classification of tumours of female reproductive organs. 4th ed. Lyon: IARC Press; 2014. p. 228–53.
Lamos C, Mihaljevic C, Aulmann S, Bruckner T, Domschke C, Wallwiener M, et al. Detection of human papillomavirus infection in patients with vaginal intraepithelial neoplasia. PLoS ONE. 2016;11: e0167386.
Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M, et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114–9.
Liu Q, Ding H, Wu YL, et al. 88 Cases of clinical analysis of vaginal intraepithelial neoplasia after hysterectomy of cervical cancer and high-grade cervical intraepithelial neoplasia. J Pract Obstet and Gynecol. 2017;33:438–42.
Audet-Lapointe P, Body G, Vauclair R, Drouin P, Ayoub J. Vaginal intraepithelial neoplasia. Gynecol Oncol. 1990;36:232–9.
Chao A, Chen TC, Hsueh C, et al. Human papillomavirus in vaginal intraepithelial neoplasia. Int J Cancer Epub. 2012;131:E259-268.
Li H, Guo YL, Zhang JX, Qiao J, Geng L. Risk factors for the development of vaginal intraepithelial neoplasia. Chin Med J (Engl). 2012;125:1219–23.
Hui Y, Manna P, Ou JJ, Kerley S, Zhang C, Sung CJ, et al. High-risk human papillomavirus infection involving multiple anatomic sites of the female lower genital tract: a multiplex real-time polymerase chain reaction-based study. Hum Pathol. 2015;46:1376–81.
Park JY, Lee KH, Dong SM, Kang S, Park SY, Seo SS. The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization. Gynecol Oncol. 2008;108:549–54.
Bogani G, Martinelli F, Ditto A, Taverna F, Lombardo C, Signorelli M, et al. Human papillomavirus (HPV) persistence and HPV 31 predict the risk of recurrence in high-grade vaginal intraepithelial neoplasia. Eur J Obstet Gynecol Reprod Biol. 2017;210:157–65.
Dodge JA, Eltabbakh GH, Mount SL, Walker RR, Morgan A. Clinical features and risk of recurrence among patients with vaginal intraepithelial neoplasia. Gynecol Oncol. 2001;83:363–9.
Karoliina T, Maija J, Karolina L, Kalliala I, Paavonen J, Nieminen P, et al. Randomised trial on treatment of vaginal intraepithelial neoplasia-Imiquimod, laser vaporisation and expectant management. Int J Cancer. 2016;139:2353–8.
Author information
Authors and Affiliations
Contributions
YZ designed the study and drafted the manuscript. RX and DC were responsible for the collection and analysis of the experimental data. YZ and XZ revised the manuscript critically for important intellectual content. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
The study was approved by Ethical Committee of Cancer Hospital of China Medical University and conducted in accordance with the ethical standards.
Informed consent
Yes.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zhang, Y., Xia, R., Chen, D. et al. Analysis of related factors of cervical intraepithelial neoplasia complicated with vaginal intraepithelial neoplasia. Clin Transl Oncol 24, 902–908 (2022). https://doi.org/10.1007/s12094-021-02739-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-021-02739-x